229 related articles for article (PubMed ID: 29335412)
41. Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies.
Granier S; Kim S; Shafer AM; Ratnala VR; Fung JJ; Zare RN; Kobilka B
J Biol Chem; 2007 May; 282(18):13895-905. PubMed ID: 17347144
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of intracellular allosteric β
Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
[TBL] [Abstract][Full Text] [Related]
43. Phosphorylation motif dictates GPCR C-terminal domain conformation and arrestin interaction.
Guillien M; Mouhand A; Sagar A; Fournet A; Allemand F; Pereira GAN; Thureau A; Bernadó P; Banères JL; Sibille N
Structure; 2023 Nov; 31(11):1394-1406.e7. PubMed ID: 37669668
[TBL] [Abstract][Full Text] [Related]
44. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
45. Phenylalanine 193 in Extracellular Loop 2 of the
Ippolito M; De Pascali F; Inoue A; Benovic JL
Mol Pharmacol; 2022 Feb; 101(2):87-94. PubMed ID: 34853152
[TBL] [Abstract][Full Text] [Related]
46. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
47. Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.
McCorvy JD; Butler KV; Kelly B; Rechsteiner K; Karpiak J; Betz RM; Kormos BL; Shoichet BK; Dror RO; Jin J; Roth BL
Nat Chem Biol; 2018 Feb; 14(2):126-134. PubMed ID: 29227473
[TBL] [Abstract][Full Text] [Related]
48. Molecular mechanism of phosphorylation-dependent arrestin activation.
Ostermaier MK; Schertler GF; Standfuss J
Curr Opin Struct Biol; 2014 Dec; 29():143-51. PubMed ID: 25484000
[TBL] [Abstract][Full Text] [Related]
49. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.
Rasmussen SG; Choi HJ; Rosenbaum DM; Kobilka TS; Thian FS; Edwards PC; Burghammer M; Ratnala VR; Sanishvili R; Fischetti RF; Schertler GF; Weis WI; Kobilka BK
Nature; 2007 Nov; 450(7168):383-7. PubMed ID: 17952055
[TBL] [Abstract][Full Text] [Related]
50. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
51. Distinct activation mechanisms of β-arrestin-1 revealed by
Zhai R; Wang Z; Chai Z; Niu X; Li C; Jin C; Hu Y
Nat Commun; 2023 Nov; 14(1):7865. PubMed ID: 38030602
[TBL] [Abstract][Full Text] [Related]
52. Computational characterization of transducer recognition of β2 adrenergic receptor.
Zhao L; He X; Jiang H; Cheng X
Biochem Biophys Res Commun; 2022 Feb; 592():67-73. PubMed ID: 35032834
[TBL] [Abstract][Full Text] [Related]
53. Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.
Macia E; Partisani M; Paleotti O; Luton F; Franco M
J Cell Sci; 2012 Sep; 125(Pt 17):4026-35. PubMed ID: 22611259
[TBL] [Abstract][Full Text] [Related]
54. Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery.
Reyes-Alcaraz A; Lee YN; Yun S; Hwang JI; Seong JY
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31305535
[TBL] [Abstract][Full Text] [Related]
55. Muscarinic receptor regulates extracellular signal regulated kinase by two modes of arrestin binding.
Jung SR; Kushmerick C; Seo JB; Koh DS; Hille B
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5579-E5588. PubMed ID: 28652372
[TBL] [Abstract][Full Text] [Related]
56. Beta
Parmar VK; Grinde E; Mazurkiewicz JE; Herrick-Davis K
Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt A):1445-1455. PubMed ID: 27993566
[TBL] [Abstract][Full Text] [Related]
57. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
[TBL] [Abstract][Full Text] [Related]
58. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
59. Insights into β2-adrenergic receptor binding from structures of the N-terminal lobe of ARRDC3.
Qi S; O'Hayre M; Gutkind JS; Hurley JH
Protein Sci; 2014 Dec; 23(12):1708-16. PubMed ID: 25220262
[TBL] [Abstract][Full Text] [Related]
60. Conformationally selective RNA aptamers allosterically modulate the β2-adrenoceptor.
Kahsai AW; Wisler JW; Lee J; Ahn S; Cahill Iii TJ; Dennison SM; Staus DP; Thomsen AR; Anasti KM; Pani B; Wingler LM; Desai H; Bompiani KM; Strachan RT; Qin X; Alam SM; Sullenger BA; Lefkowitz RJ
Nat Chem Biol; 2016 Sep; 12(9):709-16. PubMed ID: 27398998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
